Alistair Williamson
Managing Director, Lucid Group
Anisys seeks investment for international regulatory compliance and scaling of an ultra-low-cost, patented, UKCA-marked anorectal therapy. We improve access, reimbursement and margins on protocols, impacting >1% of global adult population.
Events Alistair Williamson has spoken at
- BioTrinity 2026 14 April 2026 – 15 April 2026